These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5971411)

  • 21. [Bacteriological development in the triple combination antituberculosis treatment].
    Rodríguez A; Fernández E
    Rev Med Chil; 1966 Jul; 94(7):442-5. PubMed ID: 4169808
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapy research on tuberculosis in various countries].
    Kekkaku; 1985 May; 60(5):287-92. PubMed ID: 3897687
    [No Abstract]   [Full Text] [Related]  

  • 23. Adrenal corticosteroids and tuberculosis. A statement by the Committee on Therapy.
    Am Rev Respir Dis; 1968 Mar; 97(3):484-5. PubMed ID: 4867007
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 25. The management of hypersensitivity reactions to antituberculosis drugs.
    Thompson JE
    Med J Aust; 1969 Nov; 2(21):1058-63. PubMed ID: 5373732
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.
    Pneumonologie; 1975; 151(3):167-84. PubMed ID: 1187376
    [No Abstract]   [Full Text] [Related]  

  • 27. New antituberculosis drugs and concepts of prophylaxis.
    Wolinsky E
    Med Clin North Am; 1974 May; 58(3):697-704. PubMed ID: 4362723
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of tuberculosis today in Nebraska.
    Burgher LW; Kass I
    Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990
    [No Abstract]   [Full Text] [Related]  

  • 29. A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases.
    Eidus L; Jessamine AG; Hershfield ES; Helbecque DM
    Can J Public Health; 1978; 69(2):146-53. PubMed ID: 657071
    [No Abstract]   [Full Text] [Related]  

  • 30. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis].
    Rykowska Z
    Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816
    [No Abstract]   [Full Text] [Related]  

  • 31. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A; Torning K
    Scand J Respir Dis Suppl; 1969; 69():17-20. PubMed ID: 4906371
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acute renal failure following para-aminosalicylic-acid therapy].
    Csata S; Szendi L; Koller O
    Acta Chir Acad Sci Hung; 1975; 16(2):151-4. PubMed ID: 1227221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 36. Twice-weekly streptomycin plus isoniazid for tuberculosis.
    Stradling P; Poole GW
    Tubercle; 1970 Mar; 51(1):44-7. PubMed ID: 5495335
    [No Abstract]   [Full Text] [Related]  

  • 37. [Statement on tuberculosis treatment].
    Rasmussen KN
    Ugeskr Laeger; 1973 Aug; 135(34):1829-30. PubMed ID: 4781310
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. V. September 1963 to September 1965.
    Hobby GL; Johnson PM; Crawford-Gagliardi L; Boytar V; Johnson GE
    Am Rev Respir Dis; 1966 Nov; 94(5):703-8. PubMed ID: 4958840
    [No Abstract]   [Full Text] [Related]  

  • 39. [Basophilic serological test in side effects of antituberculous drugs of the first series].
    Shmelev NA; Koviazina AI
    Probl Tuberk; 1969; 47(5):38-43. PubMed ID: 5367969
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.